In the present study, we therefore analyzed the expression of KLK9, 10, 11, 15 mRNA in a very homogeneous cohort of patients with advanced high-grade serous ovarian cancer FIGO stage III/IV, encompassing the largest subgroup of patients afflicted with ovarian cancer. Here, KLK9 is linked to ovarian carcinoma.